论文部分内容阅读
目的研究布地奈德混悬液联合特布他林雾化吸入治疗小儿毛细支气管炎临床效果。方法 110例小儿毛细支气管炎患儿,随机分为对照组和观察组,各55例。对照组患儿进行常规治疗,观察组在对照组的基础上加用布地奈德混悬液联合特布他林雾化吸入治疗。对比观察两组临床治疗效果。结果观察组总有效率为94.55%,高于对照组的80.00%,差异有统计学意义(P<0.05);观察组的患儿家属满意度为98.18%,明显高于对照组的87.27%,差异具有统计学意义(P<0.05)。结论对于小儿毛细支气管炎患儿来讲,在常规治疗的基础上采用布地奈德混悬液联合特布他林雾化吸入治疗可以显著改善临床治疗效果,提高患儿家属满意度,值得临床推广使用。
Objective To study the clinical efficacy of budesonide suspension and terbutaline in nebulization for the treatment of children with bronchiolitis. Methods 110 cases of children with bronchiolitis were randomly divided into control group and observation group, 55 cases each. Control children with conventional treatment, the observation group in the control group based on the use of budesonide suspension combined with terbutaline inhalation therapy. Compare two groups of clinical treatment effect. Results The total effective rate in the observation group was 94.55%, which was higher than that in the control group (80.00%), the difference was statistically significant (P <0.05). The satisfaction of family members in the observation group was 98.18%, significantly higher than that in the control group (87.27% The difference was statistically significant (P <0.05). Conclusion For children with pediatric bronchiolitis, the use of budesonide suspension combined with terbutaline inhalation therapy on the basis of conventional treatment can significantly improve the clinical treatment effect, improve the satisfaction of the families of children, and worthy of clinical promotion use.